A Pilot Study of High-Dose, Intravenous Ascorbic Acid (Vitamin C) to Treat Hepatitis C

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01250743
Recruitment Status : Terminated
First Posted : December 1, 2010
Last Update Posted : February 18, 2011
Information provided by:
Health Innovations, Frontier Research Institute